Article Information
History
- June 19, 2020.
Article Versions
- You are currently viewing Version 1 of this article (June 19, 2020 - 06:21).
- Version 2 (July 23, 2020 - 12:12).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ruijie Ling*,1,
- Yihan Yu*,1,
- Jiayu He3,
- Jixian Zhang1,
- Sha Xu1,
- Renrong Sun1,
- Tao Li3,†,
- Honglong Ji2,† and
- Huanqiang Wang3,†
- 1Department of respiratory medicine, Hubei Provincial Hospital of Integrated Chinese & Western Medicine, Wuhan, Hubei, China
- 2Department of Cellular and Molecular Biology, University of Texas Health Science Centre at Tyler, Tyler, Texas, USA
- 3National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China
- ↵†Correspondence to: Dr Huan-Qiang Wang, National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China. wanghq{at}niohp.chinacdc.cn; Prof Hong-Long Ji, Department of Cellular and Molecular Biology, University of Texas Health Science Centre at Tyler, Tyler, Texas, USA. James.ji{at}uthct.edu; Prof Tao Li, National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China. litao{at}niohp.chinacdc.cn
↵* Contributed equally
Posted June 19, 2020.
Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China
